ACTIVE

EPICS THERAPEUTICS

Financial year 2025 · closed on 31/12/2025
Net result
-5,8 M €
-19.7% YoY
Gross margin
4,2 M €
+4.8% YoY
Equity
9,1 M €
+15.3% YoY
Workforce
32,2 ETP
+1.6% YoY

What does EPICS THERAPEUTICS do?

EPICS THERAPEUTICS is a Public limited company incorporated in 2018. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Charleroi. It employs on average 32,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0690.759.071
Incorporation
20/02/2018
Legal form
Public limited company
Registered office
Rue Adrienne Bolland 47
6041 Charleroi · WallonieSee on map
Contributed capital
19 746 471,57 €
Latest accounts
31/12/2025
Average workforce
32,2 ETP
Joint committees (1)
  • 207
Signals
Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 7 financial years

2025202420232022202120202018
Income statement
Gross margin4,2 M €4,0 M €3,4 M €4,6 M €3,9 M €3,1 M €-521,0 k €
EBITDA925,7 k €836,1 k €394,3 k €1,7 M €1,3 M €461,4 k €-628,8 k €
Operating result-5,5 M €-4,9 M €-6,6 M €-5,6 M €-5,1 M €-5,4 M €-630,6 k €
Net result-5,8 M €-4,8 M €-6,3 M €-5,4 M €-4,6 M €-3,7 M €-630,9 k €
Balance sheet
Equity9,1 M €7,9 M €7,7 M €14,0 M €9,9 M €11,0 M €3,0 M €
Total assets14,7 M €13,8 M €9,3 M €16,0 M €11,3 M €12,2 M €3,5 M €
Cash9,2 M €8,8 M €4,2 M €12,2 M €7,8 M €8,8 M €2,3 M €
Debts5,6 M €5,5 M €1,4 M €1,7 M €1,4 M €1,2 M €521,4 k €
Other
Workforce32,2 ETP31,7 ETP32,4 ETP32,0 ETP30,6 ETP30,2 ETP0,7 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 8 active · 27 ended

Active mandates

EJM Consulting

Director · since 07 mai 2025 · until 14 mai 2030

Represented by Elisabeth Svanberg

Active
JCO Consulting

Director · since 07 mai 2025 · until 14 mai 2030 · 0693.684.414

Represented by Jean Combalbert

Active
JUNOMATI

Director · since 07 mai 2025 · until 14 mai 2030 · 0720.645.365

Represented by Bart De Leeuw

Active
Newton Biocapital Partners

Director · since 07 mai 2025 · until 14 mai 2030 · 0673.852.565

Represented by Alain Parthoens

Active
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

Director · since 07 mai 2025 · until 14 mai 2030 · 0253.445.063

Represented by Francois Fontaine

Active
SPARAXIS

Director · since 07 mai 2025 · until 14 mai 2030 · 0452.116.307

Represented by Caroline Thielen

Active
Graeme Fraser

Managing director · since 11 septembre 2024 · until 14 mai 2030

Active
GEMA

Chairman of the board of directors · since 04 février 2019 · until 07 mai 2025 · 0841.256.551

Represented by Michel Allé

Active

Ended mandates

Graeme Fraser

Managing director · since 11 septembre 2024 · until 13 mai 2025

Ended
Newton Biocapital Partners

Director · since 29 juillet 2024 · until 13 mai 2025 · 0673.852.565

Represented by Jean Combalbert

Ended
JUNOMATI

Director · since 28 juin 2024 · until 13 mai 2025 · 0720.645.365

Represented by Bart De Leeuw

Ended
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

Director · since 28 juin 2024 · until 13 mai 2025 · 0253.445.063

Represented by Francois Fontaine

Ended
At this address

Other companies at this address

CompanyCBE no.
0715.992.731
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/06/202624/11/202509/07/202417/08/202301/09/202211/06/2021
General meeting12/05/202608/05/202514/05/202411/05/202312/05/202211/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

10 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202512/05/202623/06/2026FrenchPDF
Abridged modelCorrection31/12/202408/05/202524/11/2025FrenchPDF
Abridged modelCorrection31/12/202408/05/202521/11/2025FrenchPDF
Abridged model31/12/202408/05/202513/10/2025FrenchPDF
Abridged model31/12/202314/05/202409/07/2024FrenchPDF
Abridged model31/12/202211/05/202317/08/2023FrenchPDF
Abridged model31/12/202112/05/202201/09/2022FrenchPDF
Abridged model31/12/202011/05/202111/06/2021FrenchPDF
Abridged model31/12/201912/05/202024/06/2020FrenchPDF
Abridged model31/12/201814/05/201924/05/2019FrenchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 8 active · 27 ended

Active mandates

EJM Consulting

Director · since 07 mai 2025 · until 14 mai 2030

Represented by Elisabeth Svanberg

Active
JCO Consulting

Director · since 07 mai 2025 · until 14 mai 2030 · 0693.684.414

Represented by Jean Combalbert

Active
JUNOMATI

Director · since 07 mai 2025 · until 14 mai 2030 · 0720.645.365

Represented by Bart De Leeuw

Active
Newton Biocapital Partners

Director · since 07 mai 2025 · until 14 mai 2030 · 0673.852.565

Represented by Alain Parthoens

Active
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

Director · since 07 mai 2025 · until 14 mai 2030 · 0253.445.063

Represented by Francois Fontaine

Active
SPARAXIS

Director · since 07 mai 2025 · until 14 mai 2030 · 0452.116.307

Represented by Caroline Thielen

Active
Graeme Fraser

Managing director · since 11 septembre 2024 · until 14 mai 2030

Active
GEMA

Chairman of the board of directors · since 04 février 2019 · until 07 mai 2025 · 0841.256.551

Represented by Michel Allé

Active

Ended mandates

Graeme Fraser

Managing director · since 11 septembre 2024 · until 13 mai 2025

Ended
Newton Biocapital Partners

Director · since 29 juillet 2024 · until 13 mai 2025 · 0673.852.565

Represented by Jean Combalbert

Ended
JUNOMATI

Director · since 28 juin 2024 · until 13 mai 2025 · 0720.645.365

Represented by Bart De Leeuw

Ended
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

Director · since 28 juin 2024 · until 13 mai 2025 · 0253.445.063

Represented by Francois Fontaine

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Capital / shares07/04/2026
    CAPITAL, ACTIONS
    PDF
  • Mandates03/07/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Other30/04/2025
    DIVERS
    PDF
  • Mandates13/11/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates14/08/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates16/07/2024
    CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates22/05/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates30/12/2022
    DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-5,8 M €
  2. 2024
    Annual accounts 2024-4,8 M €
  3. 2023
    Annual accounts 2023-6,3 M €
  4. 2022
    Annual accounts 2022-5,4 M €
  5. 2021
    Annual accounts 2021-4,6 M €
  6. 2020
    Annual accounts 2020-3,7 M €
  7. 2018
    Annual accounts 2018-630,9 k €
  8. 20/02/2018
    IncorporationPublic limited company